Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Salovum (Antisecretory Factor) in Patients With Severe Traumatic Brain Injury

NCT03339505 is registered in ClinicalTrials.gov with Peter Siesjö as lead sponsor.

NCT NCT03339505
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03339505 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Salovum (Antisecretory Factor) in Patients With Severe Traumatic Brain Injury
Lead sponsor
Peter Siesjö
Phase
Phase 3
Overall status
Completed
Start date
September 17, 2017
Completion date
October 10, 2022
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain trauma